Should serum IGF-I concentrations be monitored routinely during growth hormone therapy?
Papagianni
Maria
M
Great Ormond Street Hospital for Children and The Middlesex Hospital (UCLH), London, UK.
Stanhope
Richard
R
D002648:Child; D013006:Growth Hormone / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000097:blood; D007334:Insulin-Like Growth Factor I / Q000032:analysis*; D012307:Risk Factors
D018972:Insulin-Like Growth Factor Binding Protein 3; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone